[Therapy with beta-blockers in acute myocardial infarction in the aged].
Starting from the fact that during the first days the mortality is essentially determined by the degree of severity of the infarction and its complications, a particularly critical evaluation of the results is required. Patients with a bad prognosis usually have contra-indications for the application of beta-blockers during that phase. After the early complications have been overcome, the obtained findings are much easier to interpret in the sense of a therapeutical conception, and they have caused us to make the generalization--observing the contra-indications--to use beta-blockers in the framework of a complex therapy of myocardial infarction wherever it is possible. The results obtained require further verification, but justify, however, optimism on their part.